bpc 157 clinical trial Excellent Review (free!) of BPC157 Here is a quick summary of the paper including: 1. The data 2. Mechanism 3. Safety 4. “Should You Use/Try It” The Data: 36 Studies In Total FDA Panel Recommends Compounding Unapproved

AOD 9604 and BPC 157 are perfect examples

health panels move tremendously frustrating: expert Timothy Caulfield, a health law expert, said the FDA advisory panels decision is tremendously frustrating. I certainly hope that it doesnt influence what Health Canada does

Improve focus & mental clarity Protect against degenerative disease Alternative to addiction treatment Avoid medication side-effects Studies show that these treatments work best with 4 consecutive infusions

Protocol approach: frozen shoulder (adhesive capsulitis) Goal: Reduce capsular fibrosis, restore range of motion, manage pain Peptide approach: BPC-157: 300 to 500 mcg daily for anti-inflammatory and tissue healing properties TB-500: 500 to 750 mcg twice weekly for systemic anti-inflammatory and tissue remodeling Note on relaxin-2: While the most specifically targeted peptide for this condition, it remains largely in the research phase and is not widely available through standard channels Duration: Twelve to sixteen weeks (frozen shoulder has a prolonged natural course) Critical addition: Aggressive physical therapy within pain tolerance